Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenue
Product sales	$ 290,042	$ 310,867	$ 426,142	$ 703,113
Cost of product sales	119,939	100,134	185,132	295,925
Gross profit from product sales	170,103	210,733	241,010	407,188
Other Revenue
Retained royalties	22,332	5,955	40,092	70,337
Interest income				1,496
Other income	14,499	16,634	72,821	39,327
Total other revenue	36,831	22,589	112,913	111,160
Expenses
Selling expenses	22,569	125,633	126,502	306,889
Personnel and consulting expenses	219,379	277,493	839,118	1,111,058
General and administrative expenses	450,272	393,023	1,264,448	1,369,128
Interest expense	67,058	18,628	143,796	40,923
Unrealized loss on derivative instruments	49,865	15,434	41,137	24,317
Total Expenses	809,143	830,211	2,415,001	2,852,315
Income (loss) before income taxes	(602,209)	(596,889)	(2,061,178)	(2,333,967)
Provision (benefit) for income taxes
Net income (loss)	$ (602,209)	$ (596,889)	$ (2,061,078)	$ (2,333,967)
Basic income (loss) per share (in dollars per share)	$ (0.04)	$ (0.04)	$ (0.13)	$ (0.16)
Basic weighted average number of common shares outstanding (in shares)	16,867,971	15,184,765	16,205,578	14,930,809
Diluted income (loss) per share (in dollars per share)	$ (0.04)	$ (0.04)	$ (0.13)	$ (0.16)
Diluted weighted average number of common shares outstanding (in shares)	16,867,971	15,184,765	16,205,578	14,930,809